NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nanordica Medical

Nanordica Medical

Private
TallinnHealthcare & Life Scienceshttps://www.nanordica.com/

Last Round

Early Funding

Jun 10, 2026

Total Funding Raised

$8.41M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nanordica Medical is a medtech company that develops advanced antibacterial wound care products based on nanotechnology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

antibacterial wound dressingadvanced wound carechronic wound carenanotechnologymedtechdiabetic foot ulcermedical deviceinfection preventionnanomedicinenanofiber dressingsilver nanoparticlescopper nanoparticlesveterinary wound care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanordica Medical Comps

Public and private peers based on sector, stage, and business model.

Nanordica Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nanordica Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 10, 2026
SeedMay 16, 2024
GrantFeb 1, 2024
SeedFeb 6, 2023
GrantJun 15, 2022

Key People

Founding team and executive leadership

Olesja Bondarenko

Chief Executive Officer

Executive Team

Viktor Mahhov

Chief Financial Officer

Executive Team

Nanordica Medical Investors

Notable investors and investment history

Nanordica Medical investors
InvestorRounds
SuperangelSeed
European Innovation Council FundGrant
Verge HealthTech FundSeed
Estonian Business Angels NetworkEarly Funding
Health FoundersEarly Funding, Seed
AS AmalfiSeed
Specialist VCEarly Funding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 10, 2026

    $1.84M raised, led by 2C Ventures.

  • Sep 4, 2025

    Grew 23% QoQ, from 13 to 16 employees.

Nanordica Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanordica Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanordica Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersTallinn
Employee Range13
Year Founded2019
Last FundingJun 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.